DEPARTMENT OF HEALTH AND HUMAN SERVICESOctober 1st, 2019FiledOctober 1st, 2019National Cancer Institute; Development of Anti-CD30 Monoclonal Antibody; for the Development of HeFi–1, Cooperative Research and Development Agreement
National Cancer Institute; Development of Anti-CD30 Monoclonal Antibody; for the Development of HeFi–1, Cooperative Research and Development Agreement